J.B. Chemicals & Pharmaceuticals (NSE: JBCHEPHARM) has a diversified product portfolio that covers various therapeutic areas such as cardiology, dermatology, gastroenterology, neurology, and diabetology. The company’s major brands include Metrogyl, Rantac, Nicardia, Cilacar, and Chericof. In addition to its prescription drug business, J.B. Chemicals & Pharmaceuticals also has a significant presence in the OTC market in India.
The company has a strong manufacturing base in India, with four state-of-the-art manufacturing facilities that are compliant with international regulatory standards. J.B. Chemicals & Pharmaceuticals is committed to maintaining the highest standards of quality, safety, and environmental sustainability across its operations. J.B. Chemicals & Pharmaceuticals recently reported its quarterly earnings for the period ending December 31, 2022. The company’s consolidated Revenue for the quarter was ₹792.71 crore, up 32% from the same period last year. The company’s EPS for the quarter was ₹13.57, while its Net profit for the quarter was ₹106.10 crore, up 26% YoY.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,